Ann Schwartz
Position Title
Professor and Associate ChairDeputy Director and Executive Vice President of Research and Academic Affairs - Barbara Ann Karmanos Cancer Institute
Population Science
Office Location
Karmanos Cancer Institute4100 John R
Mailcode: MM04EP
Detroit, MI 48201
Office Phone
313-578-4651Office Fax
313-578-4306Education Training
Education
(1981-1986) Ph.D. Epidemiology, University of Michigan, School of Public Health, Ann Arbor, MI
(1979-1981) M.P.H. Enviornmental Health, University of Michigan School of Public Health, Ann Arbor, MI
(1978-1979) M.S. Biology, Wayne State University, Detroit, MI
(1974-1978) B.S. Zoology, University of Michigan, Ann Arbor, MI
Professional Experience
Faculty Appointments
(2010-Present) Associate Chair, Department of Oncology, Wayne State University School of Medicine, Detroit, MI
(2010-Present) Professor, Department of Oncology, Wayne State University School of Medicine, Detroit, MI
(2009-2010) Interim Associate Deam for Cancer Studies, Wayne State University School of Medicine, Detroit, MI
(2003-2010) Professor, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI
(1999-2003) Associate Professor, Department of Internal Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI
(1996-1999) Associate Professor, Department of Human Genetics, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, Pittsburgh, PA
(1993-1996) Assistant Professor, Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA
(1991-1996) Assistant Professor, Department of Clinical Epidemiology & Family Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
(1989-1991) Adjunct Assistant Professor, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
(1987-1991) Assistant Member, Michigan Cancer Foundation, Detroit, MI
Hospital and Other Professional Appointments
(2010-Present) Deputy Center Director, Karmanos Cancer Institute, Detroit, MI
(2009-2010) Interim President and CEO, Karmanos Cancer Institute, Detroit, MI
(2003-2009) Program Leader, Population Studies and Prevention Program, karmanos Cancer Institute, Detroit, MI
(2002-2009) Associate Center Director, Population Sciences, Karmanos Cancer Institute, Detroit, MI
(2000-2003) Co-Director, Community Based Research management Core, Karmanos Cancer Institute, Detroit, MI
(1999-2002) Associate Leader, Population Studies and Prevention Program, Karmanos Cancer Institute, Detroit, MI
(1994-1996) Member, University of Pittsburgh Cancer Institute, Pittsburgh, PA
Major Professional Societies
(1998-Present) Molecular Epidemiology Working Group
(1997-Present) American Association of Cancer Research
(1995-Present) Women in Cancer Research
(1992-2010) International Genetic Epidemiology Society
(1981-2010) Society for Epidemiologic Research
(1997-2007) American Society of Human Genetics
(1995-2007) American College of Epidemiology
Honors and Awards
(2013) Women in Medicine and Science Leadership Award, Wayne State University (2009-2012) University of Michigan School of Public Health Alumni Board of Governors
(2008) Center Director's Quarterly Research Award, Karmanos Cancer Institute
(2005) Awardee, 95th Percentile of the Distribution of NIH Grants over the Last 25 Years
(2005) Board of Governors Distinguished Faculty Fellowship Award, Wayne State University
(2002) Faculty Research Excellence Award, Wayne State University School of Medicine
Courses taught
CB 7430: Cancer Epidemiology
Research Interests
Epidemiology of Lung Cancer
Racial Disparities in Cancer Risk and Outcomes
Publications
1. Bollig-Fischer A, Chen W, Gadgeel SM, Wenzlaff AS, Cote ML, Schwartz AG, Bepler G. Racial diversity of actionable mutations in non-small cell lung cancer. J Thorac Oncol 2015; 10(2):250-5. PMCID:PMC4305026.
2. Xiong D, Wang Y, KupertE, Simpson C, Pinney SM, Gaba CR, Mandal D, Schwartz AG, Yang P, de Andrade M, Pikielny C, Byun J, Li Y, Stambolian D, Spitz MR, Liu Y, Amos CI, Bailey-Wilson JE, Anderson M, You M. A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Human Genet 2015; 96(2):301-8. PMCID:PMC4320264
3. Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix Sl, Chen C, Chlebowski RT, Hubbell FA, Kooperberg C, Manson JE, O’Sullivan MJ, Rohan T, Stefanick ML, Wactawski-Wende J, Wakelee H, Simon MS. Hormone use, reproductive history, and risk of lung cancer: the Women’s Health Initiative studies. J Thorac Oncol 2015; 10(7):1004-12. PMCID:PMC4627490
4. Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Lutz S, Rosenberger A, Aben KK, Andrew AS, Breslau N, Chang SC, Dieffenbach Ak, Dienemann H, Frederiksen B, Han J, Hatsukami DK, Johnson EL, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden HF, Wampfler J, Wenzlaff A, Woll P, Ziendolddiny S, Bickerboller J, Brenner H, Duell E, Haugen A, Heinrick J, Hokanson JE, Hunter DJ, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare D, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Kraft P, Amos CI, Bierut LJ. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis—a meta-analysis. J Natl Cancer Inst 2015; 107(5). PMCID: in progress
5. Schwartz AG, Cote ML. Epidemiology of lung cancer. Adv Exp Med Biol 2016; 893:21-41. PMCID: in progress
6. Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi AK, Caporaso NE, Schwartz AG, Harris CC. Differential serum cytokine levels and risk of lung cancer between African and European Americans. Cancer Epidemiol Biomarkers Prev 2015; Epub. PMCID: in progress
7. Lusk CM, Wenzlaff AS, Dyson G, Purrington KS, Watza D, land S, Soubani AO, Gadgeel SM, Schwartz AG. Whole-exome sequencing reveals genetic variability among lung cancer cases subphenotyped for emphysema. Carcinogenesis 2015; Epub: PMCID: in progress
8. Liu Y, Kheradmand F, Davis CF, Schwurer ME, Wheeler D, Tsavachidis S, Armstrong G, Simpson C, Mandal D, Kupert E, Anderson M, You M, Xiong D, Pikielny C, Schwartz AG, Bailey-Wilson J, Gaba C, De Andrade M, Yang P, Pinney SM, Genetic Epidemiology of Lung Cancer Consortium, Amos CI, Spitz MR. Focused analysis of exome sequencing data for rare germline mutations in familial and sporadic lung cancer. J Thorac Oncol 2016; 11(1):52-61. PMCID:PMC4714038
9. Bandera EV, Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM. Obesity, weight gain, and ovarian cancer risk in African American women. Int J Cancer 2016; in Press.
10. Schwartz AG, Lusk CM, Wenzlaff AS, Watza D, Pandolfi S, Mantha L, Cote ML, Soubani AO, Walworth G, Wozniak A, Neslund-Dudas C, Ardisana AA, Flynn MJ , Song T, Spizarny DL, Kvale PA, Chapman RA, Gadgeel SM. Risk of lung cancer associated with COPD phenotype based on quantitative image analysis. Cancer Epidemiol Biomarkers Prev 2016; Epub: PMCID: in progress.